Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.73 USD
Change Today -0.0132 / -1.77%
Volume 333.9K
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tae Heum Jeong D. Mgt.

Chief Financial Officer, Senior Vice President and Secretary, Rexahn Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

43$492,721
As of Fiscal Year 2014

Background*

Mr. Tae Heum Jeong, also known as Ted, MS serves as Senior Vice President of Rexahn Pharmaceuticals, Inc. Mr. Jeong has been the Chief Financial Officer and Secretary of Rexahn Pharmaceuticals, Inc. May 2005. He serves as Principal Accounting Officer of Rexahn Pharmaceuticals, Inc. He served as Chief Financial Officer of Rexahn, Corp from December 2002 to May 2005. He has extensive experience in the financial, investment and business aspects of bioscience businesses. ...

Read Full Background

Corporate Headquarters*

15245 Shady Grove Road
Rockville, Maryland 20850

United States

Phone: 240-268-5300
Fax: 240-268-5310

Board Members Memberships*

2005-2012
Chief Financial Officer, Senior Vice President and Secretary

Education*

MS
Johns Hopkins University
MS
Pohang University of Science and Technology
BS
Pohang University of Science and Technology

Other Affiliations*

Annual Compensation*

Salary$267,308
Bonus$70,800
Total Annual Compensation$338,108

Stock Options*

All Other Compensation$12,747
Exercisable Options825,000
Unexercisable Options350,000
Total Number of Options1,175,000

Total Compensation*

Total Annual Cash Compensation$350,855
Total Short Term Compensation$338,108
Other Long Term Compensation$12,747
Total Calculated Compensation$492,721
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RNN:US $0.73 USD -0.0132

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REXAHN PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.